Heavy metal urine analyses were conducted on 14 patients, ages ranging from 29 to 73 and from a variety of different occupations, before and after only one day's dose of the Oral Chelation and Longevity Plus formulas. Omegatech, King James Medical Laboratory, Inc., in Cleveland, Ohio, analyzed the urine samples.

The results showed significant excretion of all six of the heavy metals most commonly encountered and damaging to health. The following are the average percentages of increase in the 14 patients' heavy metal excretions after just one day on the formula:

Aluminum: 229%	Arsenic: 661%	Cadmium: 276%
Lead: 350%	Mercury: 773	Nickel: 9,439%

Hair analyses were conducted on two patients both before Oral Chelation and after six months on the program. After six months on the formula, each showed a significant reduction of heavy metals. In the case of a dentist who had high exposure to mercury, the six-month hair analysis showed a decrease or a normal reading in all heavy metals that were abnormally high on the first hair analysis, except for mercury which was higher. In the other case with a dental hygienist, the six-month hair analysis showed a decrease or a normal reading in all heavy metals that were abnormally high on the first analysis, except for silver which went higher.

Heavy metals can be stored deep in the tissues, brain, and nerve ganglion. When all heavy metals except one decrease after chelation, we know that this one was stored deep in the body tissue and is finally being pulled out of this tissue and mobilized for excretion. Thus, the higher readings are a positive sign that chelation is under way. In individuals with chronic or long-standing exposure to high amounts of heavy metals, the hair analysis readings can remain high and even go higher for a period of six to twelve months depending on the amount of previous exposure.

Thermology is a diagnostic imaging procedure based on measurements of heat emissions from the body. Infrared sensing devices read the heat signals and project the patterns of emission onto a computer monitor. Cells emit heat in the course of energy conversion. If there is a disturbance in the energy-conversion processes, as occurs in the case of blocked or narrowed arteries, the lessened heat emissions and reduced blood flow appear as darker areas on the thermology scan. In this way, thermology tracks the progressive deterioration of the flow of infrared energy along atherosclerotic arteries and can be used as early detection of heart disease.

The results of Dr. Hoekstra's study revealed marked improvement in blood circulation in all but one of the patients, as documented by the thermologic images. Vascularization (improved blood flow) of the feet increased by as much as 33%-significant improvements after only a six-month trial.

Nancy Gardner Heaven, director of the Foundation, states, "It appears that even though the clients selected for this study had varying complex heart conditions, all but one had an improvement of at least a 20% increase in circulation, reducing the level of stenosis (narrowing) of the vascular system. I feel very good about recommending the use of this product (Oral Chelation and Longevity Plus formulas) to my patients with cardiovascular disease or a family history where prevention is an issue."

Patient Reports on the Oral Chelation Program
In Dr. Poul's (Extended Health's Director of Research) private practice, there are currently 85 patients with a variety of health concerns who are taking the Oral Chelation and Longevity Plus formulas. They report improvement in the following conditions: headaches, cold hands or feet, skin problems, and degenerative diseases such as diabetes, autoimmune disorders, arthritis, and angina pains. They have also experienced positive effects in symptoms and conditions related to energy level, overall stamina, memory (forgetfulness), ability to concentrate, circulation, blood pressure, cholesterol and triglyceride levels, vision, respiration, and sexual drive or stamina. Research has proven the benefits of chelation for cardiovascular issues, heavy metal toxicity, and other conditions.

Summaries of the Second
Clinical Studies on the Oral Chelation and Longevity Plus Formula

Heavy metal urine analyses were conducted on eleven (n=11) patients both before and after a single dose of the Oral Chelation and Longevity Plus Formula. Age ranges in this sample were from 43 to 76, and individuals were from a variety of occupations. The single Oral Chelation dose consisted of the administration of six (6) capsules prior to sleep, and the single dose Longevity Plus consisted of the administration of six (6) caplets at the same time, prior to sleep. A first urine sample was collected prior to the administration of the Oral Chelation agents and a second urine sample was collected after the administration of the Longevity Plus agents the next day. Omegatech, King James Medical Laboratory in Cleveland, OH. analyzed each of the urine samples from the 11 patients. The results showed an increase in excretion of seven of the most toxic heavy metals most commonly encountered and damaging to health. The following are average percentage increases in heavy metal excretion in the 11 patients after just a single administration of the Oral Chelation and Longevity Plus Formula:

Aluminum: 182%	Arsenic: 320%	Cadmium: 9%	Copper: 344%

Lead: 162%	Mercury: 229%	Nickel: 43%

Four patients had blood analyzed to determine the difference in total blood cholesterol, HDL cholesterol, LDL cholesterol, VLDL cholesterol, and blood triglyceride levels before and after the Oral Chelation protocol. Blood was drawn prior to the initiation of the Oral Chelation protocol and again eight months later. Each patient administered three (3) capsules of Oral Chelation prior to sleep and three (3) caplets of Longevity Plus upon waking for an eight-month time period. Unilab in San Jose, CA analyzed the blood samples. The results show significant reductions in total blood cholesterol and triglyceride levels. The following are the average differences in blood composition from the initiation (baseline) of the protocol until its end at 8 months. Negative values indicate a decrease in the respective constituent after the eight-month time period. All values reported are in mg/dl.

Total Cholesterol: -32.5 Triglycerides: -71 HDL: -0.5
LDL: -24 VLDL: -8.05 HDL/Total Cholesterol: -0.82

The following are the average changes in blood composition as percentages for the above values:

Total Cholesterol: -16%   Triglycerides: -29%

HDL: -1%   LDL: -18%   VLDL: -16% HDL/Total Cholesterol: -15%

All categories, except HDL Cholesterol, significantly improved during this eight-month period. Each of these patients had cardiac problems prior to beginning our Oral Chelation eight-month protocol. All had either received, or had been recommended by their physician, a form of cardiac surgery in an attempt to improve their respective conditions.

A medical doctor in Alamo, California, tested one of his patients who took the Oral Chelation and Longevity Plus Formula with no other supplements or medications. After only two months of this regimen, blood tests showed significant reduction of triglycerides and LDL cholesterol, and an increase in HDL cholesterol.